CASCADIAN THERAPEUTICS INC - COM (CASC)

CUSIP: 14740B101

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM
Total 13F shares
86,828,956
Share change
-2,332,175
Total reported value
$142,391,799
Put/Call ratio
308%
Price per share
$1.64
Number of holders
69
Value change
-$2,859,431
Number of buys
28
Number of sells
26

Quarterly Holders Quick Answers

What is CUSIP 14740B101?
CUSIP 14740B101 identifies CASC - CASCADIAN THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CASCADIAN THERAPEUTICS INC - COM (CASC) as of Q3 2016

As of 30 Sep 2016, CASCADIAN THERAPEUTICS INC - COM (CASC) was held by 69 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 86,828,956 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, BVF INC/IL, NEA Management Company, LLC, FRANKLIN RESOURCES INC, venBio Select Advisor LLC, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., and DEUTSCHE BANK AG\. This page lists 69 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.